Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Top Menu

  • Indication Indication

    VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.

  • Important Safety Information
  • Patient Information
  • Full Prescribing Information
  • For Healthcare Professionals

Main Menu

  • Home
  • About ATTR-CM
    • What is ATTR-CM?
    • The impact of ATTR-CM
    • Taking action
  • Why VYNDAMAX?
    • How VYNDAMAX may help
    • How VYNDAMAX works
    • Talking to your doctor
  • Taking VYNDAMAX
    • VYNDAMAX dosing & side effects
    • Starting on VYNDAMAX
    • Staying on VYNDAMAX
  • Support and Resources
    • Financial assistance
    • Hereditary ATTR-CM resources
    • Caregiver support
    • Downloadable brochures
    • Advocacy groups
  • Sign Up
  • Indication
  • Important Safety Information
  • Patient Information
  • Full Prescribing Information
  • For Healthcare Professionals
banner

Sign up for VyndaCares™

Receive helpful information and resources throughout your treatment journey.

banner

Sign up for VyndaCares™

Receive helpful information and resources throughout your treatment journey.

VyndaCares is there for you every step of the way.

Get helpful information about ATTR-CM and VYNDAMAX.

Topics may include:

  • Understanding ATTR-CM and how it can affect the body
  • Learning how VYNDAMAX works and can help slow the progression of ATTR-CM
  • Hearing from real patients about their experience with ATTR-CM and treatment with VYNDAMAX
  • Information about financial assistance and support
  • Support, tips, tools, and other helpful resources throughout your treatment
Are you a Patient or a Caregiver?
Have you (or the person you are caring for) been prescribed VYNDAMAX?
Have you (or the person you are caring for) received the first VYNDAMAX prescription?
section 2
Privacy statement
Pfizer understands your personal and health information is private. The information you provide will only be used by Pfizer and parties acting on its behalf to send you the materials you requested and other helpful information and updates on VYNDAMAX, as well as related treatments, products, offers, and services.
By checking this box, I confirm that i am 18 years or over.
section 1
Where should we send your emails?

Would you like to receive additional support materials via mail?

NoYes
Address Info

Where would you like your additional support materials mailed?

IMPORTANT SAFETY INFORMATION AND INDICATION

View More
Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.
 

IMPORTANT SAFETY INFORMATION AND INDICATION

Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.
 
logo
Report Adverse Events Terms of Use Privacy Policy Contact Us About Pfizer Site Map
Patients should always ask their doctors for medical advice about adverse events.
You are encouraged to report adverse events related to Pfizer products by calling 1-800-438-1985 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.
This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.
© 2022 Pfizer Inc. All rights reserved.
August 2022 PP-VDM-USA-0967

IMPORTANT SAFETY INFORMATION AND INDICATION

View More
Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.

You are now leaving VYNDAMAX.com.

Links to other websites are provided as a convenience to the viewer. Pfizer accepts no responsibility for the content of linked sites.

You are now leaving VYNDAMAX.com.

The information provided in this website is intended only for healthcare professionals in the United States.

Indication

VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.